CXCR4 and hematologic disorder: Dreher et al. reported that 21 heavily pretreated patients with hematological malignancies underwent CXCR4-directed radioligand therapy using 90Y-Pentixather following CXCR4-directed 68Ga-Pentixafor PET/CT.